TY  - CHAP
AU  - Gabriel Guillén-Ruiz
AU  - Blandina Bernal-Morales
AU  - César Soria-Fregozo
AU  - Emma Virginia Herrera-Huerta
AU  - Ana Karen Limón-Vázquez
AU  - Margarita Hernández-Mixteco
AU  - Abraham Puga-Olguín
ED  - Juan Francisco Rodríguez-Landa
ED  - Jonathan Cueto-Escobedo
Y1  - 2019-12-17
PY  - 2019
T1  - Neuropharmacology of Anxiety Disorders at Young Age: A Perspective from Preclinical Research
N2  - Behavioral pharmacology studies the biological bases of behavior and the pharmacological effects of natural or synthetic drugs through behavioral analysis, with the identification of substances that could contribute to improvement of the quality of life for humans. Through behavioral pharmacology, it is possible to generate knowledge about pharmacological bases that influence the normal or altered behavior from a multidisciplinary point of view, and which includes diverse areas of science. The purpose of this book “Behavioral Pharmacology- From Basic to Clinical Research” is to show some of the advances in the identification of pharmacological properties of natural and synthetic molecules that may be used in the development of pharmacological therapies destined for the treatment of illness and disorders that affect the wellness of humans.
BT  - Behavioral Pharmacology
SP  - Ch. 6
UR  - https://doi.org/10.5772/intechopen.90486
DO  - 10.5772/intechopen.90486
SN  - 978-1-78985-680-4
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -